Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Passage Bio, Inc. (PASG) had Return on Investments of -175.52% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-7.82M |
|
-- |
|
-- |
|
$8.27M |
|
$-8.27M |
|
$0.45M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-8.27M |
|
$-8.25M |
|
3.21M |
|
3.21M |
|
$-2.44 |
|
$-2.44 |
|
| Balance Sheet Financials | |
$25.18M |
|
-- |
|
-- |
|
$25.18M |
|
$20.72M |
|
-- |
|
-- |
|
$20.72M |
|
$4.46M |
|
$4.46M |
|
$4.46M |
|
3.22M |
|
| Cash Flow Statement Financials | |
$-22.17M |
|
$0.02M |
|
-- |
|
$46.30M |
|
$24.16M |
|
$-22.15M |
|
$1.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-175.52% |
|
-175.52% |
|
-31.07% |
|
|
Return on Investments |
-175.52% |
$1.38 |
|
$-6.90 |
|
$-6.91 |
|